CIM
IONS icon

Calvert Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Calvert Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,779
Closed -$372K – 293
2016
Q4 		$372K Buy
7,779
+33
+0.4% +$1.31K 0.01% 605
2016
Q3 		$284K Buy
+7,746
New +$242K 0.01% 677
2016
Q2 		– Sell
-7,050
Closed -$286K – 786
2016
Q1 		$286K Buy
7,050
+1,868
+36% +$75.9K 0.01% 609
2015
Q4 		$321K Buy
+5,182
New +$280K 0.01% 549
2015
Q3 		– Sell
-3,733
Closed -$215K – 623
2015
Q2 		$215K Sell
3,733
-1,674
-31% -$106K 0.01% 588
2015
Q1 		$344K Buy
5,407
+1,012
+23% +$68.7K 0.02% 461
2014
Q4 		$271K Buy
+4,395
New +$217K 0.02% 495

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Calvert Investment Management's IONS Position: Q1 2017 in Review

Calvert Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 7,779 shares — an estimated $372K sold.

Calvert Investment Management first reported a position in IONS in Q4 2014 and held it in 7 quarters. The position peaked at $372K in Q4 2016. 271 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

  • Calvert Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 7,779 Ionis Pharmaceuticals shares in Q1 2017, an estimated $372K.
  • Calvert Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 7 quarters.
  • Calvert Investment Management's Ionis Pharmaceuticals position peaked at $372K in Q4 2016.
  • 271 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.